Key facts
- It has raised $410K; the latest was Later Stage VC in Feb 2025.
- Notable investors include IntegraNet Health.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for A1C
- ·The full record, as it builds
Funding rounds
No funding rounds for A1C are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About A1C
Producer of a functional beverage intended to serve diabetic, pre-diabetic, and health-conscious consumers. The company manufactures zero-sugar, zero-calorie, and zero-net-carb drinks formulated with erythritol, Ceylon cinnamon oil, aloe vera, black tea, and added vitamins, enabling consumers to consume a sweetened beverage without sugar or blood sugar spikes.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Overland Park, KS, United States
- Founded
- 2020
- Website
- a1cdrinks.com/
- Ownership
- Privately Held (backing)
A1C doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in A1C shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on A1C in its N-PORT filings yet. We sweep new filings monthly.